Innovent Biologics (OTCMKTS:IVBXF) Stock Price Down 6%

Innovent Biologics, Inc. (OTCMKTS:IVBXFGet Rating)’s stock price traded down 6% during trading on Friday . The stock traded as low as $4.74 and last traded at $4.74. 2,932 shares changed hands during trading, an increase of 34% from the average session volume of 2,183 shares. The stock had previously closed at $5.04.

Innovent Biologics Stock Performance

The firm’s 50 day moving average price is $4.85 and its 200 day moving average price is $4.75.

Innovent Biologics Company Profile

(Get Rating)

Innovent Biologics, Inc operates as a biopharmaceutical company in China. The company operates a platform for the discovery, development, and manufacture of antibody drug candidates in the fields of oncology, ophthalmology, immunology, and metabolic diseases. Its principal drug candidate is Tyvyt (sintilimab), an anti-PD-1 monoclonal antibody for the treatment of cancer, Hodgkin's lymphoma, and esophageal carcinoma.

See Also

Receive News & Ratings for Innovent Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovent Biologics and related companies with's FREE daily email newsletter.